Perspectum Completes Second Close of Series C Funding | Perspectum
Summary
The second close of the Series C funding brings the total amount raised since inception to circa $140 million.Since the beginning of 2021, 77 million US adults covered by Medicare and commercial plans have had access to LiverMultiScan, the companys flagship diagnostic tool to assess and monitor chronic liver disease. More broadly, it enables us to maintain our demonstrated leadership in the fields of medical AI techs to influence patient care both now and in the future, adds Dr Banerjee.Perspectums software products enhance the capabilities of a standard magnetic resonance imaging (MRI) machine, enabling it to capture multiparametric mapping data which allows its AI-driven software to measure organ inflammation with greater precision, aiding diagnosis and the monitoring of patients with chronic diseases.When I think of all the patients I cared for over 45 plus years, how I wish I had Perspectums AI-enabled technologies in my day," said Dr Elizabeth Fagan, Perspectum Board Member, and adjunct Professor of Internal Medicine and Pediatrics at Rush-Presbyterian-St. Lukes Medical Center, Chicago. Dr Rosenblatt adds, The funding supports a more accelerated approach as Perspectum moves to achieve its ultimate goal of standardizing the use of integrated AI clinical decision support tools for the management of patient health at scale globally.Perspectum, a global medical technology company with offices in the US, the UK, Portugal, and Singapore, delivers leading digital technologies that help clinicians provide better care for patients with chronic metabolic diseases, multi-organ pathology, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to empower patients and clinicians through quantitative assessments of health enabling early detection, diagnosis, and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers, and technologists, Perspectum offers a way to manage complex health problems at scale.